News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
Researchers question process for reviewing coverage of ‘off label’ cancer drug use
In a paper published online by the Journal of the American Medical Association, UNC Lineberger physician-researchers led by Ethan Basch, MD, MSc, raised concerns that there are inconsistencies between the five reference guides, or compendia, that the Centers for Medicare and Medicaid Services uses to determine which drugs it will reimburse for off-label uses in cancer care.
Study finds links between physicians setting cancer care guidelines and drug industry
UNC Lineberger researchers, led by Aaron Mitchell, MD, found a high prevalence of financial relationships among authors who helped develop a leading set of cancer care guidelines in the United States in a study published in JAMA Oncology. They say the work lays the foundation for future studies of whether the payments influenced clinical practice or guideline recommendations.
Researchers use genetics to probe immune system’s role in fighting cancer
Findings published in the Journal of the National Cancer Institute show that immune cells do not respond the same way to all tumor types. The study, led by UNC Lineberger researcher Benjamin Vincent, MD, could lay the foundation for the discovery of biomarkers to determine which patients might respond to certain immune-stimulating cancer treatments.
Majority of parents support HPV vaccination requirements for school, but only with opt-outs
A national survey found that parents were more likely to agree that laws requiring students to be vaccinated against HPV for school entry are a “good idea” when there is an opt-out clause.
Sharpless elected to Association of American Cancer Institutes’ Board
UNC Lineberger Comprehensive Cancer Center Director Norman E. Sharpless, MD, has won election to the Association of American Cancer Institutes’ Board of Directors.